OptimizeRx Partners with Medicom Health to Bring Automated Medication Savings Directly to Patients at Hospitals Nationwide
27 September 2018 - 2:31PM
OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital
health messaging for the pharmaceutical industry, has partnered
with Medicom Health, a software company that creates evidence-based
health and wellness applications for enriched online consumer
engagement at more than 600 hospitals nationwide.
The partnership will enable providers to automatically embed
medication savings offers for qualified patients into their
electronic health record (EHR) system workflows in real-time, as
prescribing occurs.
“By partnering with OptimizeRx, we’re taking a major step toward
empowering healthy patient outcomes post-discharge,” said Will
Sigsbee, CEO of Medicom Health. “Now more than ever, hospitals and
health systems need proven approaches that support value-based
care, reduced readmissions and improvements in the overall patient
experience. Our strategic partnership with OptimizeRx will provide
patients with drug savings options that ultimately lead to
increased medication adherence, and thus reduced readmission rates,
better patient satisfaction and improved quality metrics.”
Rising drug costs are a sizeable industry challenge, and in
recent years, copay coupons and savings vouchers have delivered
needed relief to the affordability issue. Medication adherence
improves when patients can identify ways of lowering their
co-payments, according to industry research. The strategic
partnership allows OptimizeRx to include patient savings
opportunities directly in the workflows of hospital EHRs and
demonstrate a positive impact on medication adherence and patient
outcomes.
Miriam Paramore, president of OptimizeRx, commented, “Medicom
Health’s proven ability to provide best-in-class patient engagement
for the industry’s largest health systems aligns closely with our
company’s goal to leverage a direct communication channel to
patients for pharmaceutical manufacturers offers.”
“Our strategic partnership will empower health systems that use
Epic and Cerner with connectivity to these medication savings
offers,” continued Paramore. “Connectivity to these two EHRs
through Medicom Health allows us to scale our platform and reach
millions of new patients.”
For more information, visit www.medicomhealth.com/rx-savings/
and www.optimizerx.com.
About Medicom HealthMedicom Health is an
established health technology company dedicated to empowering
health engagement via world-class digital solutions. For 18 years
the company has developed innovative, award-winning solutions for
high-profile health organizations including pharma, medical
associations & health systems. Today, over 600 leading
hospitals use Medicom Health’s best-in-class digital tools to
engage millions of consumers. For more information, visit
www.medicomhealth.com.
About OptimizeRx OptimizeRx® (NASDAQ: OPRX) is
one of the nation’s leading providers of digital health messaging
via electronic health records (EHRs), providing a direct channel
for pharma companies to communicate with healthcare providers. The
company’s cloud-based solution supports patient adherence to
medications by providing real-time access to financial assistance,
prior authorization, education, and critical clinical information.
The company’s network is comprised of leading EHR platforms like
Allscripts, Amazing Charts and Quest, and provides more than half
of the ambulatory patient market with access to these benefits
within their workflow at the point-of-care. For more information,
follow the company on Twitter, LinkedIn or
visit www.optimizerx.com.
Important Cautions Regarding Forward Looking
Statements This press release contains forward-looking
statements within the definition of Section 27A of the Securities
Act of 1933, as amended, and such as in section 21E of the
Securities Act of 1934, as amended. These forward-looking
statements should not be used to make an investment decision. The
words 'estimate,' 'possible' and 'seeking' and similar expressions
identify forward-looking statements, which speak only as to the
date the statement was made. The company undertakes no obligation
to publicly update or revise any forward-looking statements,
whether because of new information, future events, or otherwise.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted, or quantified.
Future events and actual results could differ materially from those
set forth in, contemplated by, or underlying the forward-looking
statements. The risks and uncertainties to which forward-looking
statements are subject include, but are not limited to, the effect
of government regulation, competition and other material risks.
OptimizeRx ContactDoug Baker, CFOTel (248)
651-6568 x807dbaker@optimizerx.com
Media Relations ContactNicole Brooks, Innsena
Communications(Tel) 860-800-2344nicolebrooks@innsena.com
Investor Relations ContactRon Both, CMATel
(949) 432-7557oprx@cma.team
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024